LLY

1,028

-1.37%↓

JNJ

245.17

-0.42%↓

ABBV

226.93

-0.59%↓

NVS

166.41

-0.16%↓

MRK

122.41

-1.23%↓

LLY

1,028

-1.37%↓

JNJ

245.17

-0.42%↓

ABBV

226.93

-0.59%↓

NVS

166.41

-0.16%↓

MRK

122.41

-1.23%↓

LLY

1,028

-1.37%↓

JNJ

245.17

-0.42%↓

ABBV

226.93

-0.59%↓

NVS

166.41

-0.16%↓

MRK

122.41

-1.23%↓

LLY

1,028

-1.37%↓

JNJ

245.17

-0.42%↓

ABBV

226.93

-0.59%↓

NVS

166.41

-0.16%↓

MRK

122.41

-1.23%↓

LLY

1,028

-1.37%↓

JNJ

245.17

-0.42%↓

ABBV

226.93

-0.59%↓

NVS

166.41

-0.16%↓

MRK

122.41

-1.23%↓

Search

Option Care Health Inc

Закрыт

СекторЗдравоохранение

33.39 -1.13

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

32.99

Макс.

34.2

Ключевые показатели

By Trading Economics

Доход

1.3M

52M

Продажи

19M

1.4B

P/E

Средняя по отрасли

28.111

110.024

Рентабельность продаж

3.611

Сотрудники

8,000

EBITDA

53M

156M

Рекомендации

By TipRanks

Рекомендации

Активная покупка

Прогноз на 12 месяцев

+16.79% upside

Дивиденды

By Dow Jones

Следующий отчет о доходах

28 апр. 2026 г.

Рыночная статистика

By TradingEconomics

Рыночная капитализация

1.2B

5.7B

Предыдущая цена открытия

34.52

Предыдущая цена закрытия

33.39

Новостные настроения

By Acuity

42%

58%

142 / 351 Рейтинг в Healthcare

Техническая оценка

By Trading Central

Уверенность

Bearish Evidence

Option Care Health Inc График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

24 февр. 2026 г., 23:07 UTC

Отчет

Woolworths 1st Half Profit Hit By Worker Pay Dispute, Still Boosts Dividend

24 февр. 2026 г., 23:01 UTC

Отчет

Fortescue 1st Half Net Profit, Dividend Rise on Higher Shipments, Prices -- Update

24 февр. 2026 г., 22:59 UTC

Отчет

WiseTech to Cut 2,000 Jobs as It Asks AI to Boost Profitability -- Update

24 февр. 2026 г., 22:42 UTC

Отчет

WiseTech to Cut 2,000 Jobs as It Asks AI to Boost Profitability

24 февр. 2026 г., 22:24 UTC

Приобретения, слияния, поглощения

Warner Bros. Discovery Board Says Paramount Skydance's New Proposal Could Top Netflix Agreement -- Update

24 февр. 2026 г., 23:46 UTC

Обсуждения рынка

Gold Edges Higher Amid Possible Position Adjustments -- Market Talk

24 февр. 2026 г., 23:36 UTC

Обсуждения рынка

Nikkei May Rise, Tracking Wall Street's Rebound -- Market Talk

24 февр. 2026 г., 23:30 UTC

Обсуждения рынка

Fortescue's Copper Bet Is Long Term, While Iron Ore Remains Near-Term Driver -- Market Talk

24 февр. 2026 г., 23:20 UTC

Обсуждения рынка

Fortescue Dividend Beat Overshadows Profit Miss -- Market Talk

24 февр. 2026 г., 23:20 UTC

Обсуждения рынка

Global Equities Roundup: Market Talk

24 февр. 2026 г., 23:16 UTC

Отчет

Oversea-Chinese Banking Corp.'s CEO: "Looking Ahead, We Remain Cautious Yet Positive">O39.SG

24 февр. 2026 г., 23:13 UTC

Отчет

Oversea-Chinese Banking Corp. FY25 Non-Interest Income S$5.46B Vs. S$4.72B >O39.SG

24 февр. 2026 г., 23:12 UTC

Отчет

Oversea-Chinese Banking Corp.: FY25 Net Interest Income S$9.15B Vs. S$9.76B>O39.SG

24 февр. 2026 г., 23:10 UTC

Отчет

Oversea-Chinese Banking Corp. FY25 NPL Ratio 0.9%, Unchanged on Year>O39.SG

24 февр. 2026 г., 23:10 UTC

Отчет

Oversea-Chinese Banking Corp. FY25 Net Interest Margin 1.91%, Down 29bps on Year>O39.SG

24 февр. 2026 г., 23:08 UTC

Отчет

Oversea-Chinese Banking Corp. FY25 Net S$7.42B Vs. Net S$7.59B >O39.SG

24 февр. 2026 г., 23:07 UTC

Отчет

Oversea-Chinese Banking Corp. FY25 Total Income S$14.61B Vs. S$14.47B>O39.SG

24 февр. 2026 г., 22:52 UTC

Отчет

Woolworths 1H Profit Hit By Worker Pay Dispute, Still Boosts Dividend

24 февр. 2026 г., 22:46 UTC

Отчет

Fortescue 1H Net Profit, Dividend Rise on Higher Shipments, Prices -- Update

24 февр. 2026 г., 22:31 UTC

Приобретения, слияния, поглощения

Warner Receives New Bid From Paramount -- 3rd Update

24 февр. 2026 г., 22:29 UTC

Отчет

Woolworths: FY Ebit Growth for Australian Food Expected at Upper End of Mid-to-High Single Digit Range Provided in August

24 февр. 2026 г., 22:28 UTC

Отчет

Woolworths: Australian Food Current Growth Rates Reflect Some Benefit from Cycling of Industrial Action Impacts

24 февр. 2026 г., 22:27 UTC

Отчет

Woolworths: Australian Food Sales +7.2% Excluding Tobacco in 2H First Seven Weeks

24 февр. 2026 г., 22:27 UTC

Отчет

Woolworths: Australian Food Sales +5.8% in 2H First Seven Weeks

24 февр. 2026 г., 22:25 UTC

Отчет

Woolworths: Customers Continue to be Value-Focused, Shopping Multiple Retailers in Highly Competitive Environment

24 февр. 2026 г., 22:24 UTC

Отчет

Woolworths: Trading in 3Q to Date Has Been Strong in Australian Food

24 февр. 2026 г., 22:23 UTC

Отчет

Woolworths 1H Group Sales A$37.1 Bln, Up 3.4%

24 февр. 2026 г., 22:22 UTC

Отчет

Woolworths Interim Dividend 45 Australian Cents/Share

24 февр. 2026 г., 22:22 UTC

Отчет

Woolworths 1H Profit Before Significant Items A$859 Mln, Up 16.4%

24 февр. 2026 г., 22:21 UTC

Отчет

Woolworths 1H Statutory Net Profit A$374 Mln, Down 49.4%

Сравнение c конкурентами

Изменение цены

Option Care Health Inc Прогноз

Целевая цена

By TipRanks

16.79% рост

Прогноз на 12 месяцев

Средняя 39.5 USD  16.79%

Максимум 43 USD

Минимум 37 USD

Основано на мнении 10 аналитиков Wall Street, спрогнозировавших целевые цены для Option Care Health Inc на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Активная покупка

10 ratings

9

Покупка

1

Удержание

0

Продажа

Техническая оценка

By Trading Central

31.11 / 32.41Поддержка и Сопротивление

Краткосрочная

Bearish Evidence

Среднесрочная

Neutral Evidence

Долгосрочная

Strong Bullish Evidence

Настроения

By Acuity

142 / 351Рейтинг в Здравоохранение

Новостные настроения

Свидетельства восходящего тренда

Волатильность

Ниже среднего

Объем новостей (RCV)

Выше среднего

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании Option Care Health Inc

Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as multiple sclerosis, duchenne muscular dystrophy, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.
help-icon Live chat